The Botulinum Toxin Innovation: From Powder to Liquid.
TL;DR
The shift toward ready-to-use liquid products can mitigate risks related with reconstitution errors and potentially enhancing patient care by saving time and cost associated with medication preparation.
📈 연도별 인용 (2025–2026) · 합계 2
OpenAlex 토픽 ·
Botulinum Toxin and Related Neurological Disorders
Neurological disorders and treatments
Intramuscular injections and effects
Abstract
[BACKGROUND] Botulinum toxin (BoNT) has evolved as a popular treatment for various medical and aesthetic conditions since the 1980s. The emergence of new liquid formulation BoNT products in the industry highlights the need to evaluate the value and advantages of these modern formulations.
[OBJECTIVE] The aim of this review was to assess and compare the expected difference in practice between liquid and powder formulation BoNT products.
[PAITENTS AND METHODS/MATERIALS] This article involves a review of pertinent guidelines, product information from manufacturers, available database for safety reports, and survey results.
[RESULTS] Guidelines and safety reports have pointed out potential risks in the reconstitution process, while medication preparation steps are simplified in liquid formulation.
[CONCLUSION] The shift toward ready-to-use liquid products can mitigate risks related with reconstitution errors and potentially enhancing patient care by saving time and cost associated with medication preparation.
[OBJECTIVE] The aim of this review was to assess and compare the expected difference in practice between liquid and powder formulation BoNT products.
[PAITENTS AND METHODS/MATERIALS] This article involves a review of pertinent guidelines, product information from manufacturers, available database for safety reports, and survey results.
[RESULTS] Guidelines and safety reports have pointed out potential risks in the reconstitution process, while medication preparation steps are simplified in liquid formulation.
[CONCLUSION] The shift toward ready-to-use liquid products can mitigate risks related with reconstitution errors and potentially enhancing patient care by saving time and cost associated with medication preparation.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | powder
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Botulinum toxin
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum toxin
|
scispacy | 1 | ||
| 질환 | METHODS/MATERIALS
|
scispacy | 1 |
MeSH Terms
Humans; Powders; Botulinum Toxins, Type A; Neuromuscular Agents; Drug Compounding; Botulinum Toxins
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- Correction of sunken upper eyelid with orbital fat transposition flap and dermofat graft.
- Etiology of Delayed Inflammatory Reaction Induced by Hyaluronic Acid Filler.
- Hyaluronic Acid Filler Injection Guided by Doppler Ultrasound.
- A Novel Technique for Autologous Supratip Augmentation: Septal Gap Graft.
- Ocular complications of soft tissue filler injections: A review of literature.
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.